Results 181 to 190 of about 5,699 (211)
Some of the next articles are maybe not open access.

PATH TO DIAGNOSIS IN FAMILIAL MEDITERRANEAN FEVER (FMF)

[No abstract available]
Karup, Sejla   +6 more
openaire   +2 more sources

[Familial Mediterranean Fever (FMF): from diagnosis to treatment].

Sante (Montrouge, France), 2005
Familial Mediterranean Fever (FMF), also known as paroxysmal polyserositis, is an autosomal recessive disease affecting mainly Mediterranean populations (Jews, Armenians, Arabs, Turks). It is characterised by recurrent crises of fever and serosal inflammation, leading to abdominal, thoracic or articular pain.
Myrna, Medlej-Hashim   +3 more
openaire   +1 more source

[Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].

Harefuah, 2007
Amyloidosis is the most grievous manifestation of Familial Mediterranean Fever (FMF), occurring in a high proportion of untreated patients. Continuously elevated serum amyloid A (SAA) levels during remissions, rather than a pulsatile rise during FMF attacks, underlies the development of amyloidosis.
openaire   +1 more source

Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam.

The Netherlands journal of medicine, 2019
Familial Mediterranean Fever (FMF) is the earliest described and most prevalent hereditary auto-inflammatory disease. Its clinical presentation is diverse, leading to possible delay in diagnosis and treatment. Due to immigration, FMF became common in non-Mediterranean European regions.
Hageman, I.M.G.   +4 more
openaire   +2 more sources

Trends in colchicine treatment in Familial Mediterranean fever (FMF)

2008
[No abstract available]
La Regina, M.   +3 more
openaire   +1 more source

Polyarteritis nodosa in patients with Familial Mediterranean fever (FMF): A concomitant disease or a feature of FMF?

2020
PubMed ...
Ozen, S   +6 more
openaire   +1 more source

Y688X, the first nonsense mutation in familial Mediterranean fever (FMF)

Human Mutation, 2000
C, Notarnicola   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy